Sanofi India partners with NHM MP to expand NCD, rare disease services
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
Standalone profit from operations for the quarter were Rs. 162 crores
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Standalone profit from operations for Q4-2024 were Rs. 108 crore
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Subscribe To Our Newsletter & Stay Updated